European Reference Networks & Undiagnosed Disease Networks
In addition to the four core European Reference Networks which are part of the Solve-RD project (see Solve-RD associated networks/partners) the clinical-genetic network of Solve-RD covers additionall associated ERNs, networks and undiagnosed disease programmes. These networks bring in the relevant European clinical and research experts as well as unique cohorts.
- Epi25: Collaborative for Large-Scale Whole Genome Sequencing in Epilepsy
- EpiCare: ERN on Rare and Complex Epilepsies
- ERKNet: European Rare Kidney Diseases Reference Network
- ERN BOND: ERN on Rare Bone Disorders
- ERN-Eye: ERN on Rare Eye Diseases
- ERN GUARD-Heart: ERN for Rare and Low Prevalence Complex Diseases of the Heart
- ERN-RITA: Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases Network
- MetabERN: ERN for Rare Hereditary Metabolic Disorders
- Network for Italian Genomes (NIG)
- Spanish Undiagnosed Rare Diseases Program (SpainUDP)
- Telethon Undiagnosed Disease Programme (Telethon UDP)
The Group
- Welcome
- The Project
- The Group
- Consortium
- EKUT – 1a
- EKUT – 1b
- RUMC – 2
- ULEIC – 3
- UNEW – 4
- MUH – 5
- CHU Dijon – 6a
- UB – 6b
- CNAG-CRG – 7
- EURORDIS – 8
- INSERM-Orphanet – 9a
- INSERM-ICM – 9b
- INSERM-CRM – 9c
- CUP – 10
- EMBL-EBI – 11
- JAX – 12
- KCL – 13
- UCL-IoN – 14a
- UCL-ICH – 14b
- UA – 15
- Uni Naples – 16
- UNIFE – 17
- UHB – 18
- IPATIMUP – 19
- UMCG – 20
- Charité -21
- SHU – 22
- APHP – 23
- Project Coordinator
- Project Office
- Steering Committee
- Scientific Advisory Board
- Independent Ethics Advisory Board
- Data Analysis Task Force (DATF)
- Data Interpretation Task Force (DITF)
- Associated Networks/Partners
- Collaborations
- Consortium
- Platforms & Tools
- Results
- Meetings
- News
Patient Organisations
Solve-RD is mainly collaborating with two patient organisations: EURORDIS - the voice of rare disease patients in Europe and Genetic Alliance.
Rare Disease Infrastructure
Solve-RD builds on the expertise of the most advanced and most useful diagnostic rare disease research infrastructure. We are collaborating with a number of networks, organisations, initiatives and projects.
